TCVGH and Boehringer Ingelheim signed an MOU to develop clinical trials for new drug research
2024-08-06 / GlobalBio & Investment
On6thAug,2024,TaichungVeteransGeneralHospital(TCVGH)announcedthatithadsignedanMOUwithBoehringerIngelheimtodevelopsmartclinicaltrialsfornewdrugresearchinsixmajorspecialties:pulmonary,cardio-renal-metab...
Globalbio magazine volume 112
2024-01-25 / GlobalBio & Investment
Involume112,Globalbiomagazinedivesintothenutsandboltsofimplementinginnovativemedicaltech. Breakingthroughthebarriersfromresearchtoclinicaltrialsisjustthestart,buttherealchallengekicksinaftervalidation...
The latest progress of ADC drug development in Taiwan
2024-01-25 / GlobalBio & Investment
Antibody-drugconjugates(ADCs)featurespecificityandpotentchemotherapy.Sincetheirbreakthroughintreatingsolidtumorsin2019,ADCshavebecomeahotspotforstrategicalliancesandacquisitionsamongpharmaceuticalcomp...
The latest progress of six Taiwanese CAR-T therapy developers
2024-01-25 / GlobalBio & Investment
GlobalCAR-Tdevelopmentisbustling!AlthoughTaiwanenteredtheCAR-Tfieldlateandfacedhurdleslikepatents,severalcompaniesaretargetingCAR-Tandtakingchallengestomeettheunmetneeds.Theirclinicaltrialsareexpected...
生技中心(DCB)與國衛院、高醫大攜手 加速台灣新藥開發
2018-11-29 / 記者 李林璦
今(29),財團法人生物技術開發中心(生技中心)分別與國家衛生研究院、高雄醫學大學於台灣醫療科技展簽署兩份合作備忘錄(MOU),促成生技中心與學研機構結盟,不僅將與國衛院攜手進行小分子藥物與生物藥的開發,另外,並與高醫大學共同簽約宣示參與亞洲天然物新藥研發聯盟,促進亞洲天然藥物開發,加速台灣生物科技發展。生技中心吳忠勳執行長、國衛院梁賡義院長、高雄醫學大學吳永昌教授今日出席簽約儀式,並邀請到衛福部...